Sol-Gel Technologies

SLGLNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$247.269 M

$88.00 +1.27%

Close of 7 Aug 2026

Revenue

$19.4M

#3009 by revenue

Earnings

-$6.13M

Loss-making

Shares outstanding

2,786,158

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#253Akebia TherapeuticsAKBA$252.1M
#254Emergent BioSolutionsEBS$249.7M
#255Sol-Gel TechnologiesSLGL$247.3M
#256AC ImmuneACIU$240.2M
#257OrganogenesisORGO$239.3M

Where these numbers come from

Share counts and financials for Sol-Gel Technologies are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.